Source: Business Insider
A lot is riding on the shoulders of Kabir Nath, the CEO of Compass Pathways. Scott Semler for BICompass Pathways wants to use psilocybin to help people with treatment-resistant depression. Its psilocybin pill, COMP360, could finally be coming to market as soon as next year.
Aller á la Source
Nouvelles connexes